Nina Stachenfeld

Dr. Nina Stachenfeld


Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2018 in American Journal of Physiology-Heart and Circulatory Physiology
Verified
Journal Article
Closed access
PDF file
ASAnna E. Stanhewicz
Anna E. Stanhewicz
MWMegan M. Wenner
Megan M. Wenner
NSNina Stachenfeld
Nina Stachenfeld
Diseases of the cardiovascular system are the leading cause of morbidity and mortality in men and women in developed countries, and cardiovascular disease (CVD) is becoming more prevalent in developing countries. The prevalence of atherosclerotic CVD in men is greater than in women until menopause, when the prevalence of CVD increases in women until it exceeds that of men. Endothelial function is a barometer of vascular health and a predictor of atherosclerosis that may provide insights into sex differences in CVD as well as how and why the CVD risk drastically changes with menopause. Studies of sex differences in endothelial function are conflicting, with some studies showing earlier decrements in endothelial function in men compared with women, whereas others show similar age-related declines between the sexes. Because the increase in CVD risk coincides with menopause, it is generally thought that female hormones, estrogens in particular, are cardioprotective. Moreover, it is often proposed that androgens are detrimental. In truth, the relationships are more complex. This review first addresses female and male sex hormones and their receptors and how these interact with the cardiovascular system, particularly the endothelium, in healthy young women and men. Second, we address sex differences in sex steroid receptor-independent mechanisms controlling endothelial function, focusing on vascular endothelin and the renin-angiotensin systems, in healthy young women and men. Finally, we discuss sex differences in age-associated endothelial dysfunction, focusing on the role of attenuated circulating sex hormones in these effects.

1 July 2008 in Exercise and Sport Sciences Reviews
Verified
Journal Article
Closed access
NSNina Stachenfeld
Nina Stachenfeld
In young women, estradiol and progesterone primarily control reproduction, but they also affect fluid regulation. Estradiol lowers the operating point for osmoregulation of arginine vasopressin and thirst and increases plasma volume. Although total body water and sodium content are only mildly affected, data presented in this article suggest that reproductive hormones alter homeostatic set points for body fluid and tonicity.

1 October 2001 in Journal of Applied Physiology
Verified
Journal Article
Closed access
PDF file
NSNina Stachenfeld
Nina Stachenfeld
ASAndres E. Splenser
Andres E. Splenser
WCWendy L. Calzone
Wendy L. Calzone
MTMatthew P. Taylor
Matthew P. Taylor
DKDavid L. Keefe
David L. Keefe
To determine sex differences in osmoregulation of arginine vasopressin (AVP) and body water, we studied eight men (24 ± 1 yr) and eight women (29 ± 2 yr) during 3% NaCl infusion [hypertonic saline infusion (HSI); 120 min, 0.1 ml · kg body wt−1 · min−1]. Subjects then drank 15 ml/kg body wt over 30 min followed by 60 min of rest. Women were studied in the early follicular (F; 16.1 ± 2.8 pg/ml plasma 17β-estradiol and 0.6 ± 0.1 ng/ml plasma progesterone) and midluteal (L; 80.6 ± 11.4 pg/ml plasma 17β-estradiol and 12.7 ± 0.7 ng/ml plasma progesterone) menstrual phases. Basal plasma osmolality was higher in F (286 ± 1 mosmol/kgH2O) and in men (289 ± 1 mosmol/kgH2O) compared with L (280 ± 1 mosmol/kgH2O, P < 0.05). Neither menstrual phase nor gender affected basal plasma AVP concentration (P[AVP]; 1.7 ± 4, 1.9 ± 0.4, and 2.2 ± 0.5 pg/ml for F, L, and men, respectively). The plasma osmolality threshold for AVP release was lowest in L ( x-intercept, 263 ± 3 mosmol/kgH2O, P < 0.05) compared with F (273 ± 2 mosmol/kgH2O) and men (270 ± 4 mosmol/kgH2O) during HSI. Men had greater P[AVP]-plasma osmolality slopes (i.e., sensitivity) compared with F and L (slopes = 0.14 ± 0.04, 0.09 ± 0.01, and 0.24 ± 0.07 for F, L, and men, respectively, P < 0.05). Despite similar Na+-regulating hormone responses, men excreted less Na+ during HSI (0.7 ± 0.1, 0.7 ± 0.1, and 0.5 ± 0.1 meq/kg body wt for F, L, and men, respectively, P < 0.05). Furthermore, men had greater systolic blood pressure (119 ± 5, 119 ± 5, and 132 ± 3 mmHg for F, L, and men, respectively, P < 0.05) than F and L. Our data indicate greater sensitivity in P[AVP] response to changes in plasma osmolality as the primary difference between men and women during HSI. In men, this greater sensitivity was associated with an increase in systolic blood pressure and pulse pressure during HSI, most likely due to a shift in the pressure-natriuresis curve.

1 May 2000 in Journal of Applied Physiology
Verified
Journal Article
Open access
PDF file
NSNina Stachenfeld
Nina Stachenfeld
CSCelso Silva
Celso Silva
DKDavid L. Keefe
David L. Keefe
To test the hypothesis that progestin-mediated increases in resting core temperature and the core temperature threshold for sweating onset are counteracted by estrogen, we studied eight women (24 ± 2 yr) at 27°C rest, during 20 min of passive heating (35°C), and during 40 min of exercise at 35°C. Subjects were tested four times, during the early follicular and midluteal menstrual phases, after 4 wk of combined estradiol-norethindrone (progestin) oral contraceptive administration (OC E+P), and after 4 wk of progestin-only oral contraceptive administration (OC P). The order of the OC P and OC E+P were randomized. Baseline esophageal temperature (Tes) at 27°C was higher ( P < 0.05) in the luteal phase (37.08 ± 0.21°C) and in OC P (37.60 ± 0.31°C) but not during OC E+P (37.04 ± 0.23°C) compared with the follicular phase (36.66 ± 0.21°C). Tes remained above follicular phase levels throughout passive heating and exercise during OC P, whereas Tes in the luteal phase was greater than in the follicular phase throughout exercise ( P < 0.05). The Testhreshold for sweating was also greater in the luteal phase (38.02 ± 0.28°C) and OC P (38.07 ± 0.17°C) compared with the follicular phase (37.32 ± 0.11°C) and OC E+P (37.46 ± 0.18°C). Progestin administration raised the Testhreshold for sweating during OC P, but this effect was not present when estrogen was administered with progestin, suggesting that estrogen modifies progestin-related changes in temperature regulation. These data are also consistent with previous findings that estrogen lowers the thermoregulatory operating point.

1 September 1999 in Journal of Applied Physiology
Verified
Journal Article
Closed access
PDF file
NSNina Stachenfeld
Nina Stachenfeld
CSCelso Silva
Celso Silva
DKDavid L. Keefe
David L. Keefe
CKCheryl A. Kokoszka
Cheryl A. Kokoszka
ENEthan R. Nadel
Ethan R. Nadel
To test the hypothesis that estrogen reduces the operating point for osmoregulation of arginine vasopressin (AVP), thirst, and body water balance, we studied nine women (25 ± 1 yr) during 150 min of dehydrating exercise followed by 180 min of ad libitum rehydration. Subjects were tested six different times, during the early-follicular (twice) and midluteal (twice) menstrual phases and after 4 wk of combined [estradiol-norethindrone (progestin), OC E + P] and 4 wk of norethindrone (progestin only, OC P) oral contraceptive administration, in a randomized crossover design. Basal plasma osmolality (Posm) was lower in the luteal phase (281 ± 1 mosmol/kgH2O, combined means, P < 0.05), OC E + P (281 ± 1 mosmol/kgH2O, P < 0.05), and OC P (282 ± 1 mosmol/kgH2O, P < 0.05) than in the follicular phase (286 ± 1 mosmol/kgH2O, combined means). High plasma estradiol concentration lowered the Posm threshold for AVP release during the luteal phase and during OC E + P [ x-intercepts, 282 ± 2, 278 ± 2, 276 ± 2, and 280 ± 2 mosmol/kgH2O, for follicular, luteal (combined means), OC E + P, and OC P, respectively; P < 0.05, luteal phase and OC E + P vs. follicular phase] during exercise dehydration, and 17β-estradiol administration lowered the Posm threshold for thirst stimulation [ x-intercepts, 280 ± 2, 279 ± 2, 276 ± 2, and 280 ± 2 mosmol/kgH2O for follicular, luteal, OC E + P, and OC P, respectively; P < 0.05, OC E + P vs. follicular phase], without affecting body fluid balance. When plasma 17β-estradiol concentration was high, Posm was low throughout rest, exercise, and rehydration, but plasma arginine vasopressin concentration, thirst, and body fluid retention were unchanged, indicating a lowering of the osmotic operating point for body fluid regulation.

19 March 2014
Verified
Book Chapter
Closed access
PDF file
NCNisha Charkoudian
Nisha Charkoudian
NSNina Stachenfeld
Nina Stachenfeld